{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:14:20Z","timestamp":1771859660443,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hospital-onset bacteraemia and fungaemia (HOB) has emerged as a novel surveillance metric in recent years and a prime target for automation of surveillance of healthcare-associated infections. However, real-life HOB data from European institutions remain scarce. This study explores the epidemiology of HOB at a German university hospital and describes characteristics of HOB cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective single-centre study was conducted by applying an extended version of the Providing a Roadmap for Infection Surveillance in Europe (PRAISE) automated HOB algorithm to data from the electronic health records of all in-hospital patients admitted to Charit\u00e9 university hospital between 2018 and 2022. HOB rates per 1,000 patient days were calculated for different groups of wards. Furthermore, the distribution of microorganisms, share of antimicrobial resistance, and source of possible secondary HOB (defined as HOB-causing pathogens detected in relevant clinical samples other than blood) were analysed. Additionally, patient characteristics and outcomes were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 3,648,254 patient days and 7,256 HOB with 8,357 microorganisms were included. The pooled HOB rate was 6.0 per 1,000 patient days in intensive care units, and between 0.9 and 2.0 in the various groups of non-intensive care units. Around 34.5% (n\u2009=\u20092,505) of HOB were deemed potentially secondary, with respiratory tract (37.6%, n\u2009=\u2009943) being the most common source. A total of 1,106 of 8,357 (13.2%) microorganisms were classified as multidrug-resistant, including 60.5% (23 of 38) of\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      with resistance to carbapenems. Case fatality within 14\u00a0days of HOB onset was 16.2% (990 of 6,093 patients).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Analysis of electronic health record data provides important insights into the epidemiology and characteristics of HOB cases. Substantial rates of antimicrobial resistance and case fatality underscore the relevance of HOB as an IPC metric. Results from this study may inform refinement of algorithms for automated HOB surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-026-01708-9","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:36:19Z","timestamp":1770348979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing hospital-onset bacteraemia surveillance: a five-year retrospective study following the hospital-wide implementation of an automated surveillance system at a German university hospital"],"prefix":"10.1186","volume":"15","author":[{"given":"Ferenc Darius","family":"R\u00fcther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Behnke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alberto","family":"Pe\u00f1a Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Geffers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seven Johannes Sam","family":"Aghdassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"7","key":"1708_CR1","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/S1473-3099(22)00877-5","volume":"23","author":"S Rice","year":"2023","unstructured":"Rice S, Carr K, Sobiesuo P, Shabaninejad H, Orozco-Leal G, Kontogiannis V, et al. Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review. Lancet Infect Dis. 2023;23(7):e228\u201339.","journal-title":"Lancet Infect Dis"},{"key":"1708_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-016-0149-9","volume":"6","author":"J Storr","year":"2017","unstructured":"Storr J, Twyman A, Zingg W, Damani N, Kilpatrick C, Reilly J, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control. 2017;6:6.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"1708_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1086\/507823","volume":"28","author":"I Zuschneid","year":"2007","unstructured":"Zuschneid I, Schwab F, Geffers C, Behnke M, Ruden H, Gastmeier P. Trends in ventilator-associated pneumonia rates within the German nosocomial infection surveillance system (KISS). Infect Control Hosp Epidemiol. 2007;28(3):314\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1708_CR4","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.2.1900321","author":"HRA Streefkerk","year":"2020","unstructured":"Streefkerk HRA, Verkooijen RP, Bramer WM, Verbrugh HA. Electronically assisted surveillance systems of healthcare-associated infections: a systematic review. Euro Surveill. 2020. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.2.1900321.","journal-title":"Euro Surveill"},{"key":"1708_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jhin.2021.12.021","volume":"122","author":"JDM Verberk","year":"2022","unstructured":"Verberk JDM, Aghdassi SJS, Abbas M, Naucler P, Gubbels S, Maldonado N, et al. Automated surveillance systems for healthcare-associated infections: results from a European survey and experiences from real-life utilization. J Hosp Infect. 2022;122:35\u201343.","journal-title":"J Hosp Infect"},{"issue":"Suppl 1","key":"1708_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.cmi.2021.02.028","volume":"27","author":"MSM van Mourik","year":"2021","unstructured":"van Mourik MSM, van Rooden SM, Abbas M, Aspevall O, Astagneau P, Bonten MJM, et al. PRAISE: providing a roadmap for automated infection surveillance in Europe. Clin Microbiol Infect. 2021;27(Suppl 1):S3\u201319.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"1708_CR7","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/CCM.0000000000005662","volume":"50","author":"A Gouel-Cheron","year":"2022","unstructured":"Gouel-Cheron A, Swihart BJ, Warner S, Mathew L, Strich JR, Mancera A, et al. Epidemiology of ICU-onset bloodstream infection: prevalence, pathogens, and risk factors among 150,948 ICU patients at 85 U.S. hospitals. Crit Care Med. 2022;50(12):1725\u201336.","journal-title":"Crit Care Med"},{"key":"1708_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10051009","author":"A Nutman","year":"2022","unstructured":"Nutman A, Wullfhart L, Temkin E, Feldman SF, Schechner V, Schwaber MJ, et al. Hospital-onset bloodstream infections caused by eight sentinel bacteria: a nationwide study in Israel, 2018-2019. Microorganisms. 2022. https:\/\/doi.org\/10.3390\/microorganisms10051009.","journal-title":"Microorganisms"},{"issue":"10","key":"1708_CR9","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1017\/ice.2021.528","volume":"43","author":"GM Schrank","year":"2022","unstructured":"Schrank GM, Sick-Samuels A, Bleasdale SC, Jacob JT, Dantes R, Gokhale RH, et al. Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemia. Infect Control Hosp Epidemiol. 2022;43(10):1326\u201332.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"1708_CR10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1017\/ice.2022.211","volume":"43","author":"KC Yu","year":"2022","unstructured":"Yu KC, Ye G, Edwards JR, Gupta V, Benin AL, Ai C, et al. Hospital-onset bacteremia and fungemia: an evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals. Infect Control Hosp Epidemiol. 2022;43(10):1317\u201325.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"1708_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/bmjqs-2023-016831","volume":"33","author":"S Leekha","year":"2024","unstructured":"Leekha S, Robinson GL, Jacob JT, Fridkin S, Shane A, Sick-Samuels A, et al. Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study. BMJ Qual Saf. 2024;33(8):487\u201398.","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"1708_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08082-6","volume":"23","author":"T Schaumburg","year":"2023","unstructured":"Schaumburg T, Kohler N, Breitenstein Y, Kolbe-Busch S, Hasenclever D, Chaberny IF. ICU infection surveillance can be based on electronic routine data: results of a case study. BMC Infect Dis. 2023;23(1):126.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1708_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1017\/ice.2015.261","volume":"37","author":"C Rock","year":"2016","unstructured":"Rock C, Thom KA, Harris AD, Li S, Morgan D, Milstone AM, et al. A multicenter longitudinal study of hospital-onset bacteremia: time for a new quality outcome measure? Infect Control Hosp Epidemiol. 2016;37(2):143\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"24","key":"1708_CR14","doi-asserted-by":"publisher","first-page":"2400613","DOI":"10.2807\/1560-7917.ES.2025.30.24.2400613","volume":"30","author":"SJS Aghdassi","year":"2025","unstructured":"Aghdassi SJS, van der Werff SD, Catho G, Brekelmans M, Pe\u00f1a Diaz LA, Buetti N, et al. Hospital-onset bacteraemia and fungaemia as a novel automated surveillance indicator: results from four European university hospitals. Eurosurveillance. 2025;30(24):2400613.","journal-title":"Eurosurveillance"},{"key":"1708_CR15","unstructured":"Master Organism Commensals List: National Healthcare Safety Network; 2024 [Available from: https:\/\/www.cdc.gov\/nhsn\/xls\/master-organism-com-commensals-lists.xlsx. Accessed Nov 11, 2024]."},{"key":"1708_CR16","unstructured":"European Center for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals\u2014protocol version 6.1. Stockholm: ECDC; 2022 [Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/antimicrobial-use-healthcare-associated-infections-point-prevalence-survey-version6-1.pdf. Accessed Nov 30, 2024]."},{"key":"1708_CR17","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM). Internationale Klassifikation der Krankheiten (ICD-10-GM) und Operationen- und Prozedurenschl\u00fcssel (OPS). Bonn: BfArM; 2024. [Available from: https:\/\/www.bfarm.de\/DE\/Kodiersysteme\/Klassifikationen\/_node.html. Accessed Aug 10, 2024]."},{"issue":"5","key":"1708_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"11","key":"1708_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139.","journal-title":"Med Care"},{"issue":"5","key":"1708_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2025.29","volume":"46","author":"M Brekelmans","year":"2025","unstructured":"Brekelmans M, Vlek ALM, van Dijk Y, Smilde AE, Weersink AJL, Wunderink HF, et al. Automated surveillance of hospital-onset bacteremia and fungemia: feasibility and epidemiological results from a Dutch multicenter study. Infect Control Hosp Epidemiol. 2025;46(5):1\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"1708_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1017\/ice.2017.1","volume":"38","author":"S Gubbels","year":"2017","unstructured":"Gubbels S, Nielsen J, Voldstedlund M, Kristensen B, Schonheyder HC, Ellermann-Eriksen S, et al. National Automated Surveillance of Hospital-Acquired Bacteremia in Denmark Using a Computer Algorithm. Infect Control Hosp Epidemiol. 2017;38(5):559\u201366.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"1708_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jiac.2020.01.001","volume":"26","author":"S Takaya","year":"2020","unstructured":"Takaya S, Hayakawa K, Matsunaga N, Moriyama Y, Katanami Y, Tajima T, et al. Surveillance systems for healthcare-associated infection in high and upper-middle income countries: a scoping review. J Infect Chemother. 2020;26(5):429\u201337.","journal-title":"J Infect Chemother"},{"key":"1708_CR23","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.25.2200688","author":"D Ben-David","year":"2023","unstructured":"Ben-David D, Vaturi A, Wulffhart L, Temkin E, Solter E, Carmeli Y, et al. Impact of intensified prevention measures on rates of hospital-acquired bloodstream infection in medical-surgical intensive care units, Israel, 2011 to 2019. Euro Surveill. 2023. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.25.2200688.","journal-title":"Euro Surveill"},{"issue":"6","key":"1708_CR24","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cmi.2021.12.011","volume":"28","author":"VH Mortensen","year":"2022","unstructured":"Mortensen VH, Sogaard M, Mygind LH, Wolkewitz M, Kristensen B, Schonheyder HC. Incidence and mortality of hospital-acquired bacteraemia: a population-based cohort study applying a multi-state model approach. Clin Microbiol Infect. 2022;28(6):879.","journal-title":"Clin Microbiol Infect"},{"key":"1708_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-014-0034-8","volume":"4","author":"N Culshaw","year":"2014","unstructured":"Culshaw N, Glover G, Whiteley C, Rowland K, Wyncoll D, Jones A, et al. Healthcare-associated bloodstream infections in critically ill patients: descriptive cross-sectional database study evaluating concordance with clinical site isolates. Ann Intensive Care. 2014;4:34.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"1708_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cmi.2019.10.006","volume":"26","author":"S Huber","year":"2020","unstructured":"Huber S, Hetzer B, Crazzolara R, Orth-Holler D. The correct blood volume for paediatric blood cultures: a conundrum? Clin Microbiol Infect. 2020;26(2):168\u201373.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1708_CR27","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","volume":"28","author":"AD Bai","year":"2022","unstructured":"Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, et al. Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(8):1076\u201384.","journal-title":"Clin Microbiol Infect"},{"key":"1708_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092178","author":"A Nutman","year":"2023","unstructured":"Nutman A, Temkin E, Wullfhart L, Schechner V, Schwaber MJ, Carmeli Y. Acinetobacter baumannii bloodstream infections: a nationwide study in Israel. Microorganisms. 2023. https:\/\/doi.org\/10.3390\/microorganisms11092178.","journal-title":"Microorganisms"},{"key":"1708_CR29","unstructured":"ARS Resistenzstatistik: Robert Koch Institut; [Available from: https:\/\/amr.rki.de\/Content\/Datenbank\/ARS\/ResistanceOverview.aspx. Accessed Nov 12, 2024]."},{"key":"1708_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-018-0353-x","volume":"7","author":"C Remschmidt","year":"2018","unstructured":"Remschmidt C, Schroder C, Behnke M, Gastmeier P, Geffers C, Kramer TS. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance. Antimicrob Resist Infect Control. 2018;7:54.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"1708_CR31","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/CMR.00062-05","volume":"19","author":"KK Hall","year":"2006","unstructured":"Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev. 2006;19(4):788\u2013802.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"1708_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194210","volume":"13","author":"F Schwab","year":"2018","unstructured":"Schwab F, Geffers C, Behnke M, Gastmeier P. Icu mortality following ICU-acquired primary bloodstream infections according to the type of pathogen: a prospective cohort study in 937 Germany ICUs (2006-2015). PLoS ONE. 2018;13(3):e0194210.","journal-title":"PLoS ONE"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-026-01708-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01708-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01708-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:21:47Z","timestamp":1771856507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13756-026-01708-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1186\/s13756-026-01708-9","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Charit\u00e9 University Medicine Institutional Review Board (process number: EA2\/060\/23). Informed consent was not needed for this retrospective analysis of routinely collected data within the context of the surveillance of healthcare-associated infections conducted in accordance with the German Protection against Infection Act.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Seven Johannes Sam Aghdassi serves as an Associate Editor for Antimicrobial Resistance & Infection Control. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}